ROIV ▲ +0.9% - Roivant Sciences Ltd.
$ROIV ROIVW - Priovant Announces Publication of Phase 2 BEACON Results for Brepocitinib in Cutaneous Sarcoidosis in JAMA Dermatology
10-NOV-2026 01:24 PM ET
Share this post
More filings for $ROIV
ROIV ▲ +5.6% - Roivant Sciences Ltd.Nov 9, 2026ROIV ▲ +4.0% - Roivant Sciences Ltd.Nov 9, 2026ROIV - Roivant Sciences Ltd. - SEC Filing Update (05-NOV-2026) | ThinkSabio - Stocks SimplifiedNov 5, 2026ROIV ▼ -0.2% - Roivant Sciences Ltd.Oct 29, 2026ROIV - Roivant Sciences Ltd. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 27, 2026ROIV ▲ +6.2% - Roivant Sciences Ltd.Oct 21, 2026
View full $ROIV filing history →💬 Comments
Loading comments…
Leave a comment